94 related articles for article (PubMed ID: 12352913)
1. Cytomegalovirus infection after liver transplantation: viral load as a guide to treating clinical infection.
Norris S; Kosar Y; Donaldson N; Smith HM; Zolfino T; O'Grady JG; Muiesan P; Rela M; Heaton N
Transplantation; 2002 Aug; 74(4):527-31. PubMed ID: 12352913
[TBL] [Abstract][Full Text] [Related]
2. Clinical utility of quantitative cytomegalovirus viral load determination for predicting cytomegalovirus disease in liver transplant recipients.
Humar A; Gregson D; Caliendo AM; McGeer A; Malkan G; Krajden M; Corey P; Greig P; Walmsley S; Levy G; Mazzulli T
Transplantation; 1999 Nov; 68(9):1305-11. PubMed ID: 10573068
[TBL] [Abstract][Full Text] [Related]
3. Cytomegalovirus infection: its incidence and management in cytomegalovirus-seropositive living related liver transplant recipients: a single-center experience.
Wadhawan M; Gupta S; Goyal N; Vasudevan KR; Makki K; Dawar R; Sardana R; Lal N; Kumar A
Liver Transpl; 2012 Dec; 18(12):1448-55. PubMed ID: 22903934
[TBL] [Abstract][Full Text] [Related]
4. Quantitation of cytomegalovirus DNA by the polymerase chain reaction as a predictor of disease in solid organ transplantation.
Ghisetti V; Barbui A; Franchello A; Varetto S; Pittaluga F; Bobbio M; Salizzoni M; Marchiaro G
J Med Virol; 2004 Jun; 73(2):223-9. PubMed ID: 15122796
[TBL] [Abstract][Full Text] [Related]
5. The value of pre-emptive therapy for cytomegalovirus after liver transplantation.
Müller V; Perrakis A; Meyer J; Förtsch T; Korn K; Croner RS; Yedibela S; Hohenberger W; Schellerer VS
Transplant Proc; 2012 Jun; 44(5):1357-61. PubMed ID: 22664015
[TBL] [Abstract][Full Text] [Related]
6. Comparison of a new quantitative cytomegalovirus DNA assay with other detection methods.
Macartney M; Gane EJ; Portmann B; Williams R
Transplantation; 1997 Jun; 63(12):1803-7. PubMed ID: 9210508
[TBL] [Abstract][Full Text] [Related]
7. Analysis of a quantitative PCR assay for CMV infection in liver transplant recipients: an intent to find the optimal cut-off value.
Martín-Dávila P; Fortún J; Gutiérrez C; Martí-Belda P; Candelas A; Honrubia A; Barcena R; Martínez A; Puente A; de Vicente E; Moreno S
J Clin Virol; 2005 Jun; 33(2):138-44. PubMed ID: 15911429
[TBL] [Abstract][Full Text] [Related]
8. Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation.
Emery VC; Sabin CA; Cope AV; Gor D; Hassan-Walker AF; Griffiths PD
Lancet; 2000 Jun; 355(9220):2032-6. PubMed ID: 10885354
[TBL] [Abstract][Full Text] [Related]
9. Viral load, CMV-specific T-cell immune response and cytomegalovirus disease in solid organ transplant recipients at higher risk for cytomegalovirus infection during preemptive therapy.
Martín-Gandul C; Pérez-Romero P; Blanco-Lobo P; Benmarzouk-Hidalgo OJ; Sánchez M; Gentil MA; Bernal C; Sobrino JM; Rodríguez-Hernández MJ; Cordero E;
Transpl Int; 2014 Oct; 27(10):1060-8. PubMed ID: 24964364
[TBL] [Abstract][Full Text] [Related]
10. [Commercial methods for the diagnosis of CMV infection after organ or bone marrow transplantation].
Schvoerer E; Stoll-Keller F
Ann Biol Clin (Paris); 2002; 60(4):463-7. PubMed ID: 12147450
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of PCR primers for early diagnosis of cytomegalovirus infection following liver transplantation.
Mendez JC; Espy MJ; Smith TF; Wilson JA; Paya CV
J Clin Microbiol; 1998 Feb; 36(2):526-30. PubMed ID: 9466770
[TBL] [Abstract][Full Text] [Related]
12. Preemptive therapy for cytomegalovirus based on real-time measurement of viral load in liver transplant recipients.
Sun HY; Cacciarelli TV; Wagener MM; Singh N
Transpl Immunol; 2010 Aug; 23(4):166-9. PubMed ID: 20609386
[TBL] [Abstract][Full Text] [Related]
13. Qualitative and semiquantitative polymerase chain reaction testing for cytomegalovirus DNA in serum allows prediction of CMV related disease in liver transplant recipients.
Evans PC; Soin A; Wreghitt TG; Alexander GJ
J Clin Pathol; 1998 Dec; 51(12):914-21. PubMed ID: 10070333
[TBL] [Abstract][Full Text] [Related]
14. Prophylaxis versus pre-emptive treatment for prevention of cytomegalovirus infection in CMV-seropositive orthotopic liver-transplant recipients.
Mengelle C; Rostaing L; Weclawiak H; Rossignol C; Kamar N; Izopet J
J Med Virol; 2015 May; 87(5):836-44. PubMed ID: 25655981
[TBL] [Abstract][Full Text] [Related]
15. Quantification of cytomegalovirus DNA by a fully automated real-time PCR for early diagnosis and monitoring of active viral infection in solid organ transplant recipients.
Boaretti M; Sorrentino A; Zantedeschi C; Forni A; Boschiero L; Fontana R
J Clin Virol; 2013 Feb; 56(2):124-8. PubMed ID: 23182772
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of viral load in the diagnosis of cytomegalovirus disease after liver transplantation.
Mendez J; Espy M; Smith TF; Wilson J; Wiesner R; Paya CV
Transplantation; 1998 Jun; 65(11):1477-81. PubMed ID: 9645806
[TBL] [Abstract][Full Text] [Related]
17. Impact of Cytomegalovirus Infection on Severe Hepatitis C Recurrence in Patients Undergoing Liver Transplantation.
Caston JJ; Castells L; Varo E; Gomez MA; de la Mata M; Campos-Varela I; Lumbreras C; Gonzalez-Dieguez L; Fabregat J; Herrero I; Salcedo M; Sanchez-Antolín G; Torre-Cisneros J
Transplantation; 2016 Mar; 100(3):593-9. PubMed ID: 26371595
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Preemptive Therapy and Antiviral Prophylaxis for Prevention of Cytomegalovirus in Seropositive Liver Transplant Recipients.
Liu AW; Jutivorakool K; Fisher CE; Rakita RM; Reyes JD; Bhattacharya RB; Jerome KR; Limaye AP
Transplantation; 2018 Apr; 102(4):632-639. PubMed ID: 29215460
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the Murex CMV DNA Hybrid Capture assay (version 2.0) for early diagnosis of cytomegalovirus infection in recipients of an allogeneic stem cell transplant.
Hebart H; Wuchter P; Loeffler J; Gscheidle B; Hamprecht K; Sinzger C; Jahn G; Dietz K; Kanz L; Einsele H
Bone Marrow Transplant; 2001 Jul; 28(2):213-8. PubMed ID: 11509941
[TBL] [Abstract][Full Text] [Related]
20. Time to detection of cytomegalovirus (CMV) DNA in blood leukocytes is a predictor for the development of CMV disease in CMV-seronegative recipients of allografts from CMV-seropositive donors following liver transplantation.
Manez R; Kusne S; Rinaldo C; Aguado JM; St George K; Grossi P; Frye B; Fung JJ; Ehrlich GD
J Infect Dis; 1996 May; 173(5):1072-6. PubMed ID: 8627056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
